Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness, Feasibility, and Acceptability of Targeted Antimalarial Interventions for Seasonal Migrant Populations in Metema District, Amhara Region, Ethiopia

NCT06516042 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT06516042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06516042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness, Feasibility, and Acceptability of Targeted Antimalarial Interventions for Seasonal Migrant Populations in Metema District, Amhara Region, Ethiopia
Lead sponsor
PATH
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 21, 2024
Completion date
July 31, 2025
Enrollment
10,350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, plasmodium falciparum